Literature DB >> 24648966

Association of ADAM33 gene polymorphisms with asthma in the Uygur population of China.

Jing Wang1, Jin Wen2, Mi-He-Re-Gu-Li Si-Ma-Yi3, Yuan-Bing He3, Ke-Li-Bie-Na Tu-Er-Xun3, Yu Xia3, Jian-Long Zhang3, Qi-Man-Gu-Li Wu-Shou-Er3.   

Abstract

Asthma is one of the most common chronic respiratory diseases, affecting ∼300 million children and adults worldwide. Previous studies identified a disintegrin and metalloprotease domain 33 (ADAM33) as an important susceptibility gene for asthma in patients of different nationalities; however, it is unknown whether this relationship exists in ethnically diverse populations. The present study focused on the association between single-nucleotide polymorphisms (SNPs) of the ADAM33 gene and asthma in the Uygur population of China. Three SNPs of ADAM33 (T1, S+1 and F+1) were genotyped in a case-control study among the Chinese Uygur population, involving 126 adult asthmatic patients and 126 healthy controls. The frequency of the ADAM33 T1 C allele among asthma patients was significantly higher compared to healthy controls (20.6 vs. 11.1%, P=0.003). The distribution of ADAM33 genotypes differed significantly between the two groups. The frequency of the T1 TC genotype was higher among patients compared to healthy controls [odds ratio (OR)=2.118, P=0.016] and the variant genotype, TC+CC, increased the risk of asthma (OR=2.244, P=0.005). Following adjustment for confounding factors, the ORs of TC and TC+CC for asthma were 2.317 and 2.522, respectively. There was a significant decrease in the forced expiratory volume (FEV1) levels in patients with the TC genotype compared to the TT genotype of T1. Haplotype analysis revealed that the frequencies of Hap5 (CAC) and Hap6 (CAT) were significantly higher among asthmatic patients compared to healthy controls (P=0.024 and 0.016, respectively). The genotype and allele frequencies of SNP S+1 and F+1 were not statistically different between asthmatic patients and controls. In conclusion, the ADAM33 T1 SNP may affect susceptibility to asthma in the Chinese Uygur population.

Entities:  

Keywords:  Uygur population; a disintegrin and metalloprotease domain 33; asthma; haplotype; single-nucleotide polymorphisms

Year:  2013        PMID: 24648966      PMCID: PMC3917077          DOI: 10.3892/br.2013.75

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  29 in total

Review 1.  The ADAM gene family: surface proteins with adhesion and protease activity.

Authors:  P Primakoff; D G Myles
Journal:  Trends Genet       Date:  2000-02       Impact factor: 11.639

2.  Identification and characterization of novel mouse and human ADAM33s with potential metalloprotease activity.

Authors:  Tsuyoshi Yoshinaka; Kazuhiro Nishii; Kouji Yamada; Hirohide Sawada; Eiji Nishiwaki; Katherine Smith; Kohichiro Yoshino; Hiroshi Ishiguro; Shigeki Higashiyama
Journal:  Gene       Date:  2002-01-09       Impact factor: 3.688

3.  ADAM33 gene: confirming a gene without linkage.

Authors:  D S Postma; T Howard
Journal:  Clin Exp Allergy       Date:  2004-01       Impact factor: 5.018

Review 4.  ADAMs: focus on the protease domain.

Authors:  R A Black; J M White
Journal:  Curr Opin Cell Biol       Date:  1998-10       Impact factor: 8.382

5.  Polymorphisms in a disintegrin and metalloprotease 33 (ADAM33) predict impaired early-life lung function.

Authors:  Angela Simpson; Nikolas Maniatis; Francine Jury; Julie A Cakebread; Lesley A Lowe; Stephen T Holgate; Ashley Woodcock; William E R Ollier; Andrew Collins; Adnan Custovic; John W Holloway; Sally L John
Journal:  Am J Respir Crit Care Med       Date:  2005-04-01       Impact factor: 21.405

6.  Association of a disintegrin and metalloprotease 33 (ADAM33) gene with asthma in ethnically diverse populations.

Authors:  Timothy D Howard; Dirkje S Postma; Hajo Jongepier; Wendy C Moore; Gerard H Koppelman; Siqun L Zheng; Jianfeng Xu; Eugene R Bleecker; Deborah A Meyers
Journal:  J Allergy Clin Immunol       Date:  2003-10       Impact factor: 10.793

Review 7.  The role of ADAM33 in the pathogenesis of asthma.

Authors:  Julie A Cakebread; H-M Haitchi; John W Holloway; Robert M Powell; Tim Keith; Donna E Davies; Stephen T Holgate
Journal:  Springer Semin Immunopathol       Date:  2003-11-15

8.  Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness.

Authors:  Paul Van Eerdewegh; Randall D Little; Josée Dupuis; Richard G Del Mastro; Kathy Falls; Jason Simon; Dana Torrey; Sunil Pandit; Joyce McKenny; Karen Braunschweiger; Alison Walsh; Ziying Liu; Brooke Hayward; Colleen Folz; Susan P Manning; Alicia Bawa; Lisa Saracino; Michelle Thackston; Youssef Benchekroun; Neva Capparell; Mei Wang; Ron Adair; Yun Feng; JoAnn Dubois; Michael G FitzGerald; Hui Huang; René Gibson; Kristina M Allen; Alex Pedan; Melvyn R Danzig; Shelby P Umland; Robert W Egan; Francis M Cuss; Steuart Rorke; Joanne B Clough; John W Holloway; Stephen T Holgate; Tim P Keith
Journal:  Nature       Date:  2002-07-10       Impact factor: 49.962

9.  The role of polymorphisms in ADAM33, a disintegrin and metalloprotease 33, in childhood asthma and lung function in two German populations.

Authors:  Michaela Schedel; Martin Depner; Carola Schoen; Stephan K Weiland; Christian Vogelberg; Bodo Niggemann; Susanne Lau; Thomas Illig; Norman Klopp; Ulrich Wahn; Erika von Mutius; Renate Nickel; Michael Kabesch
Journal:  Respir Res       Date:  2006-06-19

10.  Adam33 polymorphisms are associated with COPD and lung function in long-term tobacco smokers.

Authors:  Alireza Sadeghnejad; Jill A Ohar; Siqun L Zheng; David A Sterling; Gregory A Hawkins; Deborah A Meyers; Eugene R Bleecker
Journal:  Respir Res       Date:  2009-03-12
View more
  2 in total

1.  ADAM33 gene polymorphisms identified to be associated with asthma in a Chinese Li population.

Authors:  Bo Shen; Rong Lin; Cai-Chun Wang; Jing Rei; Yan Sun; Yong-Le Yang; Ying-Ying Lin
Journal:  Biomed Rep       Date:  2017-02-08

2.  Haplotype analysis of ADAM33 polymorphisms in asthma: A pilot study.

Authors:  Sangeetha Vishweswaraiah; Nallur B Ramachandra; B S Jayaraj; Amrutha D Holla; Samarpana Chakraborty; Anurag Agrawal; Padukudru A Mahesh
Journal:  Indian J Med Res       Date:  2019-09       Impact factor: 2.375

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.